FibroBiologics, Inc. 8-K Report Highlights: Key Updates as of December 2024

Based on the provided section of the financial report, here are the key pieces of information extracted:

1. Company Information:

• Name: FibroBiologics, Inc.
• CIK Number: 0001958777
• Location: 455 E. Medical Center Blvd, Suite 300, Houston, TX 77598
• Phone Number: (281) 671-5150
• Ticker Symbol: FBLG
• Exchange: NASDAQ

2. Report Details:

• Filing Type: 8-K (current report)
• Filing Date: December 20, 2024

3. Stock Information:

• Common Stock: Par value of $0.00001 per share
  

4. Financial Context:

• Reporting Period: The report is as of December 20, 2024.
• Currency: All amounts are in USD.
• Measurement Units: Financial figures are presented in USD and shares.

5. Regulatory Information:

• SEC Accession Number: 001-41934
• EIN: 86-3329066

Insights:

• The 8-K filing indicates that this report could contain significant events or corporate changes occurring at FibroBiologics as of the specified date.
• The company is publicly traded and listed on NASDAQ, suggesting a level of regulatory scrutiny and compliance requirements.
• The par value of the common stock is extremely low, which may indicate a relatively low initial capital structure or a focus on attracting investors with minimal capital requirements per share.

Overall, this section provides a concise overview of important corporate, regulatory, and financial details essential for understanding FibroBiologics, Inc.'s current standing in the market.